SS
TXG icon

Steve Schonfeld’s 10x Genomics TXG Stock Holding History

Steve Schonfeld’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-113,724
Closed -$2.41M – 3022
2026
Q1 		$2.41M Buy
+113,724
New +$2.27M 0.02% 745
2025
Q4 		– Sell
-82,126
Closed -$960K – 2597
2025
Q3 		$960K Buy
82,126
+24,639
+43% +$321K 0.01% 1387
2025
Q2 		$666K Buy
57,487
+26,558
+86% +$242K ﹤0.01% 1452
2025
Q1 		$270K Sell
30,929
-120,764
-80% -$1.52M ﹤0.01% 1833
2024
Q4 		$2.18M Buy
151,693
+88,583
+140% +$1.4M 0.01% 797
2024
Q3 		$1.43M Buy
63,110
+37,890
+150% +$783K 0.01% 1033
2024
Q2 		$491K Sell
25,220
-7,477
-23% -$196K ﹤0.01% 1502
2024
Q1 		$1.23M Buy
32,697
+11,047
+51% +$485K 0.01% 1154
2023
Q4 		$1.21M Buy
+21,650
New +$942K 0.01% 967
2023
Q3 		– Sell
-8,800
Closed -$491K – 2304
2023
Q2 		$491K Buy
+8,800
New +$476K ﹤0.01% 1229
2022
Q4 		– Sell
-34,200
Closed -$974K – 3023
2022
Q3 		$974K Buy
+34,200
New +$1.3M 0.01% 1283
2021
Q2 		– Sell
-12,281
Closed -$2.22M – 2328
2021
Q1 		$2.22M Sell
12,281
-219
-2% -$37.8K 0.03% 632
2020
Q4 		$1.77M Buy
12,500
+2,630
+27% +$382K 0.02% 629
2020
Q3 		$1.23M Buy
9,870
+770
+8% +$80.8K 0.02% 651
2020
Q2 		$813K Hold
9,100
– – 0.02% 670
2020
Q1 		$567K Buy
+9,100
New +$710K 0.04% 540

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steve Schonfeld's TXG Position: Q2 2026 in Review

Steve Schonfeld sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 113,724 shares — an estimated $2.41M sold.

Steve Schonfeld first reported a position in TXG in Q1 2020 and held it in 16 quarters. The position peaked at $2.41M in Q1 2026. 389 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Steve Schonfeld reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 113,724 10x Genomics shares in Q2 2026, an estimated $2.41M.
  • Steve Schonfeld first reported a position in 10x Genomics in Q1 2020 and held it in 16 quarters.
  • Steve Schonfeld's 10x Genomics position peaked at $2.41M in Q1 2026.
  • 389 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.